Clinical trials
Phase 2 Heart Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 11 |
| Recruiting | 6 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardurion Pharmaceuticals, Inc. | 4 |
| Duke University | 3 |
| Indiana University | 3 |
| Eli Lilly and Company | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| University Hospitals Cleveland Medical Center | 2 |
| Abcentra | 1 |
| Akcea Therapeutics | 1 |
| Arizona State University | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 45 |
| Cardiovascular Diseases | 22 |
| Coronary Artery Disease | 10 |
| Coronary Disease | 7 |
| Heart Failure | 7 |
| Myocardial Ischemia | 5 |
| Vascular Diseases | 5 |
| Arterial Occlusive Diseases | 4 |
| Arteriosclerosis | 4 |
| Myocardial Infarction | 4 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.